Globus Medical Announces ExcelsiusGPS® Milestone: 3,000 screws implanted

NEXT STORY
Apellis Pharmaceuticals Announces First Patient Enrolled in Phase 3 APL-2 Head-to-Head Study in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Treated with Soliris™
PREV STORY
The US Supreme Court Grants Review for Certiorari of a Federal Circuit Panel Ruling that US Patent Protection for Aloxi® in the US Market was Invalid
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

GeoVax Announces Appointment of David Dodd as Chairman, President and Chief Executive Officer

Current President & CEO Robert McNally to Retire Effective August 31 ATLANTA, GA, Aug. ...

author_avatar
NASDAQ Market News

Poseida Provides Update on Phase 1 Study of P-BCMA-101 CAR-T Stem Cell Memory Product in Patients with Relapsed/Refractory Multiple Myeloma

Efficacy and safety continue to be a major advantage, with a very high response ...

author_avatar
NASDAQ Market News

Acupath Laboratories Announces Expansion of COVID-19 Test Offerings With Introduction of Low-Cost Saliva PCR Assay

author_avatar
NASDAQ Market News